Efficacy of chemotherapy after hormone therapy for hormone receptor–positive metastatic breast cancer
Objective: According to the guidelines for metastatic breast cancer, hormone therapy for hormone receptor–positive metastatic breast cancer without life-threatening metastasis should be received prior to chemotherapy. Previous trials have investigated the sensitivity of chemotherapy for preoperative...
Main Authors: | Ryutaro Mori, Yasuko Nagao |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-11-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312114557376 |
Similar Items
-
The efficacy of second-line hormone therapy for recurrence during adjuvant hormone therapy for breast cancer
by: Ryutaro Mori, et al.
Published: (2014-03-01) -
Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
by: Li Bian, et al.
Published: (2020-10-01) -
High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
by: Ryutaro Mori, et al.
Published: (2014-06-01) -
Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib
by: Ajay Dhakal, et al.
Published: (2020-07-01) -
Optimal management of hormone receptor positive metastatic breast cancer in 2016
by: Tomas Reinert, et al.
Published: (2015-11-01)